Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Dividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Healthstream (HSTM) Gains from Investment Securities (2016 - 2025)

Historic Gains from Investment Securities for Healthstream (HSTM) over the last 15 years, with Q3 2025 value amounting to $90000.0.

  • Healthstream's Gains from Investment Securities fell 7383.72% to $90000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $90000.0, marking a year-over-year decrease of 9699.9%. This contributed to the annual value of $90000.0 for FY2024, which is 0.0% changed from last year.
  • Per Healthstream's latest filing, its Gains from Investment Securities stood at $90000.0 for Q3 2025, which was down 7383.72% from $90000.0 recorded in Q2 2025.
  • In the past 5 years, Healthstream's Gains from Investment Securities ranged from a high of $7.5 million in Q4 2024 and a low of -$568000.0 during Q4 2021
  • In the last 5 years, Healthstream's Gains from Investment Securities had a median value of $272000.0 in 2022 and averaged $803444.4.
  • Data for Healthstream's Gains from Investment Securities shows a peak YoY increase of 231250.0% (in 2021) and a maximum YoY decrease of 22678.57% (in 2021) over the last 5 years.
  • Quarter analysis of 5 years shows Healthstream's Gains from Investment Securities stood at -$568000.0 in 2021, then skyrocketed by 135.21% to $200000.0 in 2022, then skyrocketed by 797.0% to $1.8 million in 2023, then surged by 317.84% to $7.5 million in 2024, then plummeted by 98.8% to $90000.0 in 2025.
  • Its Gains from Investment Securities was $90000.0 in Q3 2025, compared to $90000.0 in Q2 2025 and $1.1 million in Q1 2025.